top of page
醫生的案頭

AD-LVA case study

Subscribe to Our Newsletter

Thanks for submitting!

All Videos

All Videos

All Videos
Search video...
why AD-LVA works for Brain degenerative disorders

why AD-LVA works for Brain degenerative disorders

01:43
Play Video
Alzheimer's stage II case performed by Prof. Qingping Xie

Alzheimer's stage II case performed by Prof. Qingping Xie

05:12
Play Video
Severe AD with language barrier

Severe AD with language barrier

04:20
Play Video
AD patient with Aphasia

AD patient with Aphasia

05:50
Play Video

Overview about the disease:

Overview:

Recent advancements in the supermicrosurgical treatment of arm/leg lymphedema have yielded remarkable success. Concurrently, groundbreaking research has uncovered dysfunction in the brain’s lymphatic system, leading to the identification of Alzheimer’s disease (AD) as a form of “lymphedema of the brain.” This revelation presents a promising pathway for exploring the potential application of lymphatic supermicrosurgery in the treatment of AD.

The neurodegenerative diseases described here (listed alphabetically) include:

 

- Alzheimer's disease

- Amyotrophic lateral sclerosis (ALS)

- Friedrich's ataxia

- Huntington's disease

- Multiple sclerosis

- Parkinson's disease

- Prion diseases

- Spinocerebellar ataxia

- Spinal muscular atrophy

Screenshot 2025-01-03 204703.png

Amyotrophic Lateral Sclerosis (ALS) –

ALS, commonly referred to as "Lou Gehrig's disease" in the United States, is a motor neuron disease. It results in the selective loss of motor neurons, which regulate communication between the nervous system and voluntary muscles. Typically, ALS is a rapidly progressive disease and is almost always fatal.

 

For more information, please refer to the Amyotrophic Lateral Sclerosis (ALS) Overview: http://www.ninds.nih.gov/disorders/amyotrophiclateralsclerosis/detail_ALS.htm"

 

Our clinical treatment results:

 

 

Parkinson’s disease:

Parkinson's disease causes a gradual degeneration of a specific area in your brain known as the basal ganglia. As this area deteriorates, you begin to lose the abilities controlled by these regions. Researchers have discovered that Parkinson's disease leads to significant changes in the brain's chemical composition.

 

Under normal circumstances, your brain uses chemical substances called neurotransmitters to control communication between brain cells (neurons). When you have Parkinson's disease, an essential neurotransmitter, dopamine, is lacking in your brain.

 

Your brain uses dopamine-dependent cells to fine-tune your movements when sending activation signals to your muscles. This is why the lack of dopamine triggers symptoms of slowed movement and tremors in Parkinson's disease.

 

As Parkinson's disease progresses, symptoms broaden and intensify. In the later stages of the disease, it often affects your brain functions, leading to dementia-like symptoms and depression.

bottom of page